BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 23419247)

  • 1. Risk factors predisposing relapse of bullous pemphigoid at initial diagnosis: A retrospective cohort study of 205 patients.
    Liu Y; Wang Y; Zhang J; Chen F; Cui S; Wang Y; Jin H; Li L
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111082. PubMed ID: 37913571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous pemphigoid.
    Miyamoto D; Santi CG; Aoki V; Maruta CW
    An Bras Dermatol; 2019; 94(2):133-146. PubMed ID: 31090818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and prognostic factors of Bullous Pemphigoid in a Moroccan population.
    Titou H; Hjira N
    Australas J Dermatol; 2022 Aug; 63(3):328-334. PubMed ID: 35500129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality of patients with bullous pemphigoid in Korea.
    Lee JH; Kim SC
    J Am Acad Dermatol; 2014 Oct; 71(4):676-83. PubMed ID: 24930586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities.
    Liu J; Xiang T; Wang W; Bu Z
    Clin Cosmet Investig Dermatol; 2022; 15():1391-1396. PubMed ID: 35903519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
    Chen X; Zhang Y; Luo Z; Wu Y; Niu T; Zheng J; Xie Y
    PLoS One; 2022; 17(4):e0264705. PubMed ID: 35427358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid.
    Shen WC; Chiang HY; Chen PS; Lin YT; Kuo CC; Wu PY
    JAMA Dermatol; 2022 Feb; 158(2):167-175. PubMed ID: 34964804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous pemphigoid associated with psoriasis: a good response to methotrexate.
    Vargas P; Giacaman P; Fernández J; Morales C
    An Bras Dermatol; 2019; 94(2):224-226. PubMed ID: 31090831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and Comorbidity Profiles of Patients with Bullous Pemphigoid in Korea.
    Jeon HW; Yun SJ; Lee SC; Won YH; Lee JB
    Ann Dermatol; 2018 Feb; 30(1):13-19. PubMed ID: 29386827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis.
    Liu YD; Wang YH; Ye YC; Zhao WL; Li L
    Arch Dermatol Res; 2017 Jul; 309(5):335-347. PubMed ID: 28317060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.
    Brick KE; Weaver CH; Lohse CM; Pittelkow MR; Lehman JS; Camilleri MJ; Al-Hashimi M; Wieland CN
    J Am Acad Dermatol; 2014 Jul; 71(1):92-9. PubMed ID: 24704091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center.
    Kremer N; Zeeli T; Sprecher E; Geller S
    Int J Dermatol; 2017 Oct; 56(10):1010-1016. PubMed ID: 28856675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
    Kjellman P; Eriksson H; Berg P
    Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.
    Wang TS; Tsai TF
    Acta Derm Venereol; 2014 Jan; 94(1):108-9. PubMed ID: 23624752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bullous pemphigoid: a review].
    Bernard P; Charneux J
    Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid.
    Gaitanis G; Alexis I; Pelidou SH; Gazi IF; Kyritsis AP; Elisaf MS; Bassukas ID
    Eur J Dermatol; 2012; 22(3):363-9. PubMed ID: 22548754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study.
    Zhang LM; Wu J; Xiao T; Jin GY; Li JH; Geng L; He CD; Gao XH; Chen HD
    Eur J Dermatol; 2013; 23(1):94-8. PubMed ID: 23419247
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.